Back to Search
Start Over
CLINICAL OUTCOMES FOLLOWING TRANSCATHETER MITRAL VALVE REPAIR VERSUS MEDICAL THERAPY FOR SECONDARY MITRAL REGURGITATION IN PATIENTS WITH PREVIOUSLY IMPLANTED CARDIAC RESYNCHRONIZATION THERAPY: THE COAPT TRIAL
- Source :
- Journal of the American College of Cardiology. 75:1111
- Publication Year :
- 2020
- Publisher :
- Elsevier BV, 2020.
-
Abstract
- Patients with heart failure (HF) who remain symptomatic despite cardiac resynchronization therapy (CRT) have a poor prognosis. The impact of transcatheter mitral valve repair (TMVr) for secondary mitral regurgitation (MR) in patients with previously implanted CRT is unknown. In the COAPT trial, 614
- Subjects :
- medicine.medical_specialty
Mitral regurgitation
Poor prognosis
genetic structures
business.industry
medicine.medical_treatment
Cardiac resynchronization therapy
medicine.disease
Internal medicine
Heart failure
cardiovascular system
medicine
Cardiology
Transcatheter mitral valve repair
In patient
cardiovascular diseases
Cardiology and Cardiovascular Medicine
business
Medical therapy
Subjects
Details
- ISSN :
- 07351097
- Volume :
- 75
- Database :
- OpenAIRE
- Journal :
- Journal of the American College of Cardiology
- Accession number :
- edsair.doi...........8e8b7eed18ffd39fb61a0abceabe4b6e
- Full Text :
- https://doi.org/10.1016/s0735-1097(20)31738-1